Evaluation of the clinical sensitivity and specificity of the BD Max™ Enteric Bacterial Panel for molecular detection of pathogens for acute gastroenteritis in the Singaporean population

Koo, Seok Hwee; Heng, Ying Xuan; Jiang, Boran; Ng, Lily Siew Yong; Sim, Diana Miao Fang; Tan, Thean Yen

doi:10.1016/j.mimet.2022.106478

Cited by 2 publications

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent study examining the aetiology of acute gastroenteritis using stool specimens collected between February and October 2016 reported that Campylobacter(9.4%, 28/299) was the second leading bacterial pathogen detected, following Salmonella(19.1%, 57/299) (Koo et al, 2022). Chau et al examined the presence of enteric pathogens in faecal samples collected from adult patients with acute diarrhea between October 2013 and January 2014 using multiplex PCR (Chau et al, 2015).…”

Section: Singaporementioning

confidence: 99%

See 1 more Smart Citation

Global epidemiology of campylobacteriosis and the impact of COVID-19

Liu

Lee

Xue

et al. 2022

Front. Cell. Infect. Microbiol.

View full text Add to dashboard Cite

Campylobacteriosis is a gastroenteritis caused by pathogenic Campylobacter species and an important topic in public health. Here we review the global epidemiology of campylobacteriosis in the last eight years between 2014-2021, providing comprehensive and updated information on the reported incidence and outbreaks of Campylobacter infections. The government public health website of each of the 195 countries and publications from 2014 to September 2022 in public databases were searched. The reported incidence of campylobacteriosis in pre-COVID-19 years was compared to that during the COVID-19 pandemic in countries where data were available. Czech Republic had the highest reported incidence of campylobacteriosis worldwide (215 per 100,000 in 2019), followed by Australia (146.8 per 100,000 in 2016) and New Zealand (126.1 per 100,000 in 2019). Campylobacter was one of the most common human enteric pathogens in both developed and developing countries. About 90% of cases of campylobacteriosis were caused by Campylobacter jejuni, whereas less than 10% of cases were caused by Campylobacter coli. Other Campylobacter species were also isolated. The reported incidence and case numbers of campylobacteriosis in developed nations have remained steadily high prior to the COVID-19 pandemic, whilst some countries reported an increasing trend such as France and Japan. While outbreaks were more frequently reported in some countries, Campylobacter infections were mainly sporadic cases in most of the developed countries. Campylobacter infection was more common in summer in some but not all countries. Campylobacter infection was more common in males than females. The COVID-19 pandemic has reduced the reported incidence of campylobacteriosis in most countries where 2020 epidemiology data were available. In conclusion, Campylobacter infection remains a global health concern. Increased research and improved strategies are needed for prevention and reduction of Campylobacter infection.

show abstract

Section: Singaporementioning

confidence: 99%

Section: Epidemiologymentioning

confidence: 99%

Global epidemiology of campylobacteriosis and the impact of COVID-19

Liu

Lee

Xue

et al. 2022

Front. Cell. Infect. Microbiol.

View full text Add to dashboard Cite

show abstract

Campylobacter and Arcobacter

Nachamkin

2023

ClinMicroNow

View full text Add to dashboard Cite

Two closely related genera, Campylobacter and Sulfurospirillum , are currently included in the family Campylobacteraceae . Arcobacter , previously included in the family Campylobacteraceae, is now classified as the sole species in its own family, Arcobacteraceae . C. jejuni and C. coli have been recognized since the early 1970s as agents of gastrointestinal infection. Numerous commercially available fecal antigen detection systems for Campylobacter in stool samples are cleared by the Food and Drug Administration in the United States. Nucleic acid amplification tests are now commonly being used to directly detect Campylobacter and other enteric pathogens in stool samples. Typing systems for Campylobacter epidemiologic studies vary in complexity and in their ability to discriminate between strains. Serologic testing appears to be useful for epidemiologic investigations but is not recommended for routine diagnosis of campylobacter infection.

show abstract

Evaluation of the clinical sensitivity and specificity of the BD Max™ Enteric Bacterial Panel for molecular detection of pathogens for acute gastroenteritis in the Singaporean population

Cited by 2 publications

References 23 publications

Global epidemiology of campylobacteriosis and the impact of COVID-19

Global epidemiology of campylobacteriosis and the impact of COVID-19

Campylobacter and Arcobacter

Contact Info

Product

Resources

About